[1]
Grigorescu, A.C. and Teodorescu, L.M. 2020. Tirosyne Kinase Inhibithors (TKIs) in the Treatment of Non –Small Cell Lung Cancer (NSCLC), Practical Pharmacological Aspects. Journal of Drug Delivery and Therapeutics. 10, 1 (Jan. 2020), 135–138. DOI:https://doi.org/10.22270/jddt.v10i1.3830.